Team

iStride™ Device Leadership Team/Influencers

DAVID HUIZENGA

DAVID HUIZENGA

Founder and CEO

David E. Huizenga is the founder and CEO of Moterum Technologies Inc., a medical device company in stroke rehabilitation. He is an expert in translating groundbreaking science into realistic commercial opportunities. Over the last 5 years, he has focused his efforts on the unique needs of the neural rehabilitation patient.
Previously, David was CEO and cofounder of Tao Life Sciences LLC, an early stage life sciences technology development and investment company, which successfully monetized over half of its portfolio. David has been on the founding team of numerous life science companies, and has involvement in successful acquisitions and exits. David has served in a variety of corporate management roles including, as the Chief Technology Officer of Zirus, Inc. an antiviral company, where he was engaged in management of the Zirus patent portfolio, licensing, and competitive intelligence. Mr. Huizenga was a leader in the translation of the company’s science strategy to its patent and business strategy.
Before joining the Zirus team, Mr. Huizenga was a partner and the founding member and head of the Patent Team at Arnall Golden Gregory, and prior to this he was a shareholder, and the Chief Financial Officer and Vice President of Venture Investment at Needle & Rosenberg, PC. Mr. Huizenga obtained his Ph.D. from Harvard, in the laboratory of Jack Szostak, Nobel Laureate in Medicine, and his Law Degree from Emory University Law School, where he was a Woodruff Fellow. Mr. Huizenga serves on numerous corporate and non-profit boards.

LAUREN RASHFORD

LAUREN RASHFORD

Director of Clinical Operations and Customer Development

Lauren is the Director of Clinical Operations and Customer Development at Moterum Technologies. She has a strong background in both clinical and commercial rehabilitation and offers a viewpoint and expertise in the medical device field. Lauren holds a doctorate in physical therapy and has specialized in the neurologic rehabilitation population.  Lauren plays an integral role in bringing the device from the workbench to the clinical setting. Prior to joining Moterum, Lauren has been a lead Physical Therapist at several outpatient clinics specializing in Stroke, SCI, and Amputee populations; where she was asked to be a guest speaker at the New England Amputee Association. Additionally, Lauren played a vital role working with ReWalk Robotics, a state of the art robotic exoskeleton device, in developing and managing the Southeast Territory.

Lauren received her Doctorate in Physical Therapy from the University of Rhode Island, following a BA in Education/Sociology from Brandeis University. Lauren was selected as an American Physical Therapy Association (APTA) Core Ambassador while recieving her DPT. Lauren also holds an advanced certification as a dry needling specialist. 
Currently, Lauren is leading our home-based clinical trials for the iStride™ device as Principal Investigator as well as managing customer relations.

Board of Directors

David G. Perryman

David G. Perryman

Chairman

David Perryman, J.D., is Chief Operating Officer of Drug Innovation Ventures at Emory University (DRIVE) in Atlanta.  He was formerly President, CEO and a founder of Zirus. David has played many roles in his 25 years in the biotechnology industry. In addition to Zirus, David has founded two other biotechnology companies: one was acquired and the second became a publicly traded company. David has served on the Board of Directors of these and other biotechnology companies. Prior to joining Zirus, he was a shareholder and head of the Biotechnology Patent Practice group at Needle & Rosenberg, an IP boutique law firm. He practiced biotechnology patent law for 20 years delivering patent business strategy to biotech companies, venture capital funds, the CDC, NIH, FDA and numerous universities. He also served as a founder and special advisor to Georgia Venture Partners, a state associated biotech venture capital fund. David served as a panelist at the Institute of Medicine’s Countermesure/Bioterrorism policy meeting (2010) as well as a featured presenter in Developments in Biodefense and Technology Platforms at the 8th Annual BioDefense Summit 2010. He received the 2014 Industry Growth Award from GaBio, considered the top award in Georgia for contribution to the state’s biotechnology industry.

Cooper Collins

Cooper Collins

Mr. Cooper C. Collins, MBA, serves as the Managing Partner and CIO of MagnaSci Venture funds and as an Advisor to a number of pharmaceutical and biotechnology companies. Mr. Collins is the Founder and Advisor of Pernix Therapeutics Holdings, Inc. He served as the Chief Strategic Officer of Pernix Therapeutics Holdings, Inc. from May 2013 to April 15, 2014 and also served as its President from January 2007 to May 2013 and Chief Executive Officer from June 2008 to May 2013. He served as the President and Chief Executive Officer of Pernix Therapeutics, LLC. From December 2005 to December 2007, he served as Vice President of Business and Product Development at Pernix and from December 2003 to December 2005, he served as Pernix’s Territory Manager. He was responsible for acquiring companies and products, attracting investors and increasing the overall efficiency. He served at the NFL franchise The New Orleans Saints in their media relations department for three years. He has been a Director of Oncternal Therapeutics, Inc. since February 22, 2017. He has been an Independent Director of TherapeuticsMD, Inc. since February 28, 2012. He serves as a Director of Pernix Sleep, Inc. and Anthem Vault Inc. He served as a Director of Pernix Therapeutics Holdings, Inc. from January 1, 2007 to February 2014. Mr. Collins earned a BA and an MBA from Nicholls State University in Thibodaux, Louisiana.

Karan Sorenson

Karan Sorenson

Karan Sorensen is an expert in digital health, information technologies, and the “internet of things”. Through her previous roles as a CIO and head of Digital Health for companies, such as Johnson & Johnson Pharmaceutical Research & Development LLC and Life Technologies, she pioneered global programs in the digital health arenas, such as Johnson and Johnson’s Total Oncology Digital Health Program. Her excellence in the digital health world has garnered numerous awards including, Bio-IT World Best Practices, CIO magazine and CIO.COM awards including the CIO 100 award and CIO 100+ Competitive Advantage award. She has special expertise in executing innovation, information and technology solutions, building businesses, implementing operational excellence programs and developing leaders. Karan has been called a visionary and inspirational leader adept at shaping technical and business strategies, creating an energetic climate for growth and excellence, delivering large-scale goals, and motivating others to achieve their highest levels of growth and performance. She has a reputation for excellence in creating high performance global teams and organizations and for administering multi-million dollar budgets. A technopreneur, Karan serves as a board member and advisor for technology start-ups, colleges, universities and industry standards organizations.

David Huizenga

View Bio

Board of Advisors

Brian Dorsey

Brian Dorsey

Brian T. Dorsey is a Partner and Managing Director of MagnaSci Ventures, a boutique life science venture fund out of Houston, Texas. He has been the Senior Vice President, Chief Development Officer, of Apricus since December 2014. Brian has served in the pharmaceutical and biotechnology industries for over 20 years where he has provided high-level drug development, regulatory and QC/QA leadership of pharmaceutical candidates from early development to FDA approval. He has held various senior management roles with pharmaceutical companies, most recently at Pernix Therapeutics as Senior Vice President Pharmaceutical Development from April 2013 to September 2014. Brian held managerial positions of increasing responsibility at Somaxon Pharmaceuticals from 2005 to 2013, and before that at Baxter Bioscience and Pfizer Global Research and Development.
Brian received his Master of Science in Executive Leadership and his B.A. in Chemistry from the University of San Diego. Mr. Dorsey received his Master of Science in Executive Leadership and his B.A. in Chemistry from the University of San Diego.

Brian Cummings

Brian Cummings

Brian Cummings is currently a Managing Director and Partner in Alta Ventures Fund II, a high technology venture fund based in Salt Lake City, Utah. Brian has had a successful career in starting hundreds of technology based companies and is passionate about changing the way in which breakthrough technologies get commercialized. He is a Founder and/or CXO of a number breakthrough companies including Mu Therapeutics – developing a novel vaccines for addiction, Technium – a SAAS company that analyzes and aggregates Big Ideas, and Motive – an accelerator based on Lean principles. Brian has generated over $100 million in licensing and ventures revenue and was most recently Vice President of Technology Commercialization at Ohio State University and President of the Ohio State Innovation Foundation. In that role, he transformed the office and led the creation of over 20 new entrepreneurial based programs, tripled the number of start-ups, doubled the number of inventions, and increased the portfolio valuation over 30 fold. Previously, he was Executive Director of the Technology Commercialization Office at the University of Utah and Associate Vice President for Technology Ventures. Brian has set up multiple seed and venture capital funds and with his partner, Paul Ahlstrom, developed a unique seed funding model called KickStart to align early stage investors. Previously, Brian led the life science commercialization efforts at the University of Texas and structured one of its largest deals to date. Brian has served on multiple Boards including e-SENS Inc., Tao Ventures, Catheter Connections, The Rocky Mountain Research Center for Emerging Infectious Diseases, The Governor’s Board for Business Resource Centers, The Kickstart Seed Fund, The Renaissance Foundation, The Edison Institute, SciTech the LES Board for Technology Commercialization Structure and Development and Alta Innovation Institute.

Dr. Kyle Reed

Dr. Kyle Reed

Dr. Kyle B. Reed is an international leader in the Biomechanics and Mechanical Engineering needs of rehabilitation patients. He has published many research papers, book chapters, and conference proceedings in the field of engineering and rehabilitation. Associate Professor, Mechanical Engineering, University of South Florida. He was a Fellow working jointly in the world renowned laboratories of Collaborative Haptics and Robotics in Medicine Lab at Stanford University (Haptics Exploration) and the Locomotion in Mechanical and Biological Systems (LIMBS) Laboratory at Johns Hopkins University (LIMBS).
He received his Ph.D. from Northwestern University, working in the Neuroscience and Robotics Lab (LIMS). He is a leader in Human-Robot-Human (HRH) interactions, with particular applicability to physical therapy. This work is particularly impactful in the implementation of Moterum Technologies’ iStrideTM device system which links up the activities and efforts of the stroke user during their rehabilitation and all those they want to share this with, such as their grandchildren and friends which links up the activities and efforts of the stroke user during their rehabilitation and all those they want to share this with, such as their grandchildren and friends. Dr. Reed is a Co-Inventor of the iStride Device, and Director of the Gait Laboratory, and is currently a tenured Associate Professor at the University of South Florida, Department of Mechanical Engineering, 2016-present.
Assistant Professor, University of South Florida, Department of Mechanical Engineering.

Elizabeth DuBose

Elizabeth DuBose

Elizabeth DuBose received her Doctorate in Physical Therapy in 2008, from the Medical University of South Carolina, along with an M.S. in Rehabilitation Science, Physical Therapy. She is certified in the Neuro-­IFRAH approach by Waleed Al-­Oboudi, a Certified Brain Injury Specialist, and has an Advanced Gait certification in the Neuro-­IFRAH approach. Elizabeth is currently the Manager of Therapies at Greenville Health System-­Roger C Peace Rehabilitation Hospital and the Greenville Memorial Hospital Sub-Acute unit both in Greenville, SC and North Greenville Long Term Acute Care Hospital in Travelers Rest, SC. She is active and involved in the stroke program at Greenville Memorial Hospital, which is a Comprehensive Stroke Center certified by the Joint Commission and sits on the Greenville Memorial stroke advisory team. She has held numerous clinical positions, in outpatient and inpatient settings, with specializations and emphasis on neurorehabilitation. Elizabeth has been instrumental in helping Roger C Peace receive five CARF (Commission on Accreditation of Rehabilitation Facilities) accreditations for Spinal Cord Injury, Brain Injury, Stroke, Amputee, and Comprehensive Rehabilitation. She is on the Board of Directors, and current Board Chair, of the Brain Injury Association of South Carolina (BIASC) and is the co-­founder and current co-­chair of the main fundraiser for the BIASC, the Run for Thought 5K, which has raised over $180,000 over the last nine years. She also is a member of Anderson University’s Physical Therapy School Program Advisory Council, and she sits on the Regulatory and Legislative Committee of the American Medical Rehabilitation Providers Association. Elizabeth is the Co-Inventor of the Lower Limb Stretching device, and PI of the South Carolina Spinal Cord Injury Research Foundation grant: “Lower Limb (Ankle) Stretching via the Vittori device” for a clinical trial of the Lower Limb Stretching device, one of Moterum Technologies Pipeline Products.

Charles Goetz

Charles Goetz

Charles Goetz joined Goizueta Business School in the fall of 2001. Prior to his foray into academia, he had over fifteen years of experience in developing, implementing and growing entrepreneurial ventures. Goetz has been responsible for starting and building nine new ventures to date, employing more than 1,000 employees and delivering returns to investors in many cases far exceeding initial investment expectations. These companies operated in six unique industries including: banking, healthcare, radio broadcasting, sports, real estate and advertising. He has been awarded three patents and numerous copyrights. Goetz is still actively involved in investing in new businesses and sits on a number of both private business and not-for-profit boards.

As a lecturer, Goetz teaches BBA, MBA, Executive MBA and PhD students’ the following courses: Introduction to Entrepreneurship, Applied Entrepreneurship, Business Development, and directed study.

Goetz has written three books. They are: The Great Entrepreneurial Divide – The Winning Tactics of Successful Entrepreneurs and Why Everyone Else Fails! and So You Want to Start a Business? – 8 Steps to Take Before Making the Leap. His third book is his first novel, a political thriller. It is titled Angels of Conspiracy and will be released soon.

In addition, Goetz is responsible for the development of “Marketnomics,” a mathematical model based on calculus that quantifies perceived customer value by product features resulting in product offerings with substantially greater value propositions at lower costs and higher demand.

Goetz is regularly interviewed by both local and national media on small business and entrepreneurship topics. Examples of recent interviews include: CNN: Small businesses that do well in recessions; NPR: What small businesses need to do to be successful in difficult times; Fox News: The implications on small business of the health care legislation.

Douglas Goldstein

Douglas Goldstein

@eFuturist

Douglas is a leader in accelerating growth of digital and biohealth companies through leadership, business development and marketing that delivers value and results. As an entrepreneur and intrapreneur he has crafted innovative solutions using technology, process improvement and human ingenuity.  

He is a thought leader in digital therapeutics, population health and precision health. He is the author of 11 books health and technology including “eHealthcare: Harness the Power of e-Commerce and e-Care”and “Medical Informatics 20/20 – Quality and EHRs through Collaboration, Open Solutions and Innovation.” His forthcoming book is “We Are Data.”  As a thought leader he has delivered over 300 talks and workshops for leading health and life sciences organizations.

Recently, Doug served as the Innovation Officer for the Inova Center for Personalized Health where he led the development of new value and outcome based clinical and business relationships with global life sciences and medical device companies. In this role he worked with in excess of 50 leading global life sciences, medical devices and healthcare leaders on new solutions.The Inova Center for Personalized Health is 117 acre campus on the Washington DC beltway that is being transformed into a translational research, drug discovery and innovation center. 

Previously, Doug serve as a senior executive leading innovation and development for HealthGrades, Inc., Wolters Kluwer Innovation Lab, PatientPoint, Merck’s Vree Health and others.   As CEO of Health Online, Inc., he was a first mover in the syndicated health Web portal services market and raised $4.2M in capital from BancBoston Ventures and Allina Health. Doug was also an early innovator in digital mobile health services.  In 2008, as CEO of iConecto, Inc. he developed “[email protected]” which wasa mobile, social, gaming App experienceintegrating cognitive PTSD therapy and physical therapyfor Wounded Warriors. The solution was a finalist in VAi2 Innovation Grant Program. 

Currently, he is the Managing Director of eFuturist, Inc. which delivers insights, innovations and solutions to guide leaders in navigating the dynamics of today’s fitness, health and medical markets, smarter.

 

We design, develop, and test high impact products in the field of mobility and rehabilitation

Our projects arise from recognizing the unsolved problems of mobility challenged people.  We solve these problems with new technology that we develop to help you and your family live full lives. Our company is focused on sourcing, designing, engineering, manufacturing and selling the highest quality products to significantly impact people through addressing the problems of stroke rehabilitation and other chronic neural disorders.

Currently we have made a next generation device, which is currently being tested in a home based trial, for which we are actively recruiting participants.